Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within T2N1M0 stage hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study based on SEER database.

Yuhang ShangXuelian WangYansong LiuWeilun ChengYunqiang DuanZhengbo FangJiangwei LiuFanjing KongTing WangTianshui YuAnbang HuJiarui ZhangHanyu ZhangMingcui LiZhiyuan RongYanling LiSuborna S ShakilaXinxin LiJianyuan FengFei MaBaoliang Guo

Published in: Breast cancer (Tokyo, Japan) (2024)

Among T2N1M0 stage HR + /HER2- patients, OS and BCSS of NACT were inferior to ACT. Patients who attained non-pCR after NACT demonstrated significantly worse survival outcomes compared with those who received ACT.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
rectal cancer
lymph node
peritoneal dialysis
emergency department
radiation therapy
locally advanced
drug induced